| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Cheif Executive Officer | CEO +4 more
2 companies
Fried Robert N serves as a Chief Executive Officer at NAGE and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 12 buys and 1 sell. Those positions are worth an estimated $3.3M at current prices.
Historically, Fried Robert N's trades have earned a middling insider score of 51/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +4.8%.
The biggest single holding is NAGE (~$3.2M) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 162,690 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2016 | FLNT Fluent, Inc. | Director | Buy | 2,000 | $3.75 | $7,500.00 | +0.6% | |
| Sep 1, 2016 | NAGE Niagen Bioscience, Inc. | - | Buy | 15,000 | $3.39 | $50,850.00 | +28.9% | |
| Jan 29, 2016 | NAGE Niagen Bioscience, Inc. | Director | Sell | 5,063 | $1.26 | $6,379.38 | -3.1% |